Quantification and Significance of Diffuse Myocardial Fibrosis and Diastolic Dysfunction in Childhood Hypertrophic Cardiomyopathy

被引:24
|
作者
Hussain, Tarique [1 ,2 ]
Dragulescu, Andreea [1 ]
Benson, Lee [1 ]
Yoo, Shi-Joon [1 ,3 ]
Meng, Howard [1 ]
Windram, Jonathan [1 ,3 ]
Wong, Derek [1 ,3 ]
Greiser, Andreas [4 ]
Friedberg, Mark [1 ]
Mertens, Luc [1 ]
Seed, Michael [1 ,3 ]
Redington, Andrew [1 ]
Grosse-Wortmann, Lars [1 ,3 ]
机构
[1] Univ Toronto, Hosp Sick Children, Dept Pediat, Labatt Family Heart Ctr, Toronto, ON M5G 1X8, Canada
[2] Kings Coll London, St Thomas Hosp, Rayne Inst, Div Imaging Sci & Biomed Engn, London SE1 7EH, England
[3] Univ Toronto, Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada
[4] Siemens AG Healthcare Sector, Erlangen, Germany
关键词
Child; Adolescent; Hypertrophic cardiomyopathy; Cardiovascular magnetic resonance imaging; Echocardiography; CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR FILLING PRESSURES; LATE GADOLINIUM ENHANCEMENT; NATRIURETIC PEPTIDE; PROGNOSTIC VALUE; DISEASE; ECHOCARDIOGRAPHY; CHILDREN; STRAIN;
D O I
10.1007/s00246-015-1107-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to evaluate the presence of diffuse myocardial fibrosis in children and adolescents with hypertrophic cardiomyopathy (HCM) and to assess associations with echocardiographic and clinical parameters of disease. While a common end point in adults with HCM, it is unclear whether diffuse myocardial fibrosis occurs early in the disease. Cardiac magnetic resonance (CMR) estimation of myocardial post-contrast longitudinal relaxation time (T1) is an increasingly used method to estimate diffuse fibrosis. T1 measurements were taken using standard multi-breath-hold spoiled gradient echo phase-sensitive inversion-recovery CMR before and 15 min after the injection of gadolinium. The tissue-blood partition coefficient was calculated as a function of the ratio of T1 change of myocardium compared with blood. An echocardiogram and blood brain natriuretic peptide (BNP) levels were obtained on the day of the CMR. Twelve controls (mean age 12.8 years; 7 male) and 28 patients with HCM (mean age 12.8 years; 21 male) participated. The partition coefficient for both septal (0.27 +/- A 0.17 vs. 0.13 +/- A 0.09; p = 0.03) and lateral walls (0.22 +/- A 0.09 vs. 0.07 +/- A 0.10; p < 0.001) was increased in patients compared with controls. Eight patients had overt areas of late gadolinium enhancement (LGE). These patients did not show increased partition coefficient compared with those without LGE (0.27 +/- A 0.15 vs. 0.27 +/- A 0.19 and 0.22 +/- A 0.09 vs. 0.22 +/- A 0.09; p = 0.95 and 0.98, respectively). However, patients who were symptomatic (dyspnea, arrhythmia and/or chest pain) had higher lateral wall partition coefficient than asymptomatic HCM patients (0.27 +/- A 0.08 vs. 0.17 +/- A 0.08; p = 0.006). Similarly, patients with raised BNP (> 100 pg/ml) had raised lateral wall coefficients (0.27 +/- A 0.07 vs. 0.20 +/- A 0.07; p = 0.03), as did those with traditional risk factors for sudden death (0.27 +/- A 0.06 vs. 0.18 +/- A 0.08; p = 0.007). Diffuse fibrosis, measured by the partition coefficient technique, is demonstrable in children and adolescents with HCM. Markers of fibrosis show an association with symptoms and raised serum BNP. Further study of the prognostic implication of this technique in young patients with HCM is warranted.
引用
收藏
页码:970 / 978
页数:9
相关论文
共 50 条
  • [1] Quantification and Significance of Diffuse Myocardial Fibrosis and Diastolic Dysfunction in Childhood Hypertrophic Cardiomyopathy
    Tarique Hussain
    Andreea Dragulescu
    Lee Benson
    Shi-Joon Yoo
    Howard Meng
    Jonathan Windram
    Derek Wong
    Andreas Greiser
    Mark Friedberg
    Luc Mertens
    Michael Seed
    Andrew Redington
    Lars Grosse-Wortmann
    Pediatric Cardiology, 2015, 36 : 970 - 978
  • [2] Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction
    Andris H Ellims
    Leah M Iles
    Liang-han Ling
    James L Hare
    David M Kaye
    Andrew J Taylor
    Journal of Cardiovascular Magnetic Resonance, 14
  • [3] Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction
    Ellims, Andris H.
    Iles, Leah M.
    Ling, Liang-han
    Hare, James L.
    Kaye, David M.
    Taylor, Andrew J.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2012, 14
  • [4] Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
    Tarique Hussain
    Andrea Dragulescu
    Lee Benson
    Derek Wong
    Mark Friedberg
    Luc Mertens
    Shi-Joon Yoo
    Lars Grosse-Wortmann
    Journal of Cardiovascular Magnetic Resonance, 15 (Suppl 1)
  • [5] Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
    Deraz, Salem Elsayed
    Esmat, Omar Deyaa
    Abd El-Hmid, Rehab Galal
    Amin, Sayed Ali
    EGYPTIAN HEART JOURNAL, 2023, 75 (01):
  • [6] Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
    Salem Elsayed Deraz
    Omar Deyaa Esmat
    Rehab Galal Abd El-Hmid
    Sayed Ali Amin
    The Egyptian Heart Journal, 75
  • [7] Diastolic dysfunction in hypertrophic cardiomyopathy is related to myocardial fibrosis as determined by cardiovascular magnetic resonance
    Alsaileek, AA
    Valeti, U
    Alvarez, L
    Breen, J
    Ommen, S
    Seward, JB
    Nishimura, RA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 50A - 50A
  • [8] Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
    Hanlon, R. O'
    Grasso, A.
    Roughton, M.
    Moon, J. C.
    Wage, W.
    Bucciarelli-Ducci, C.
    Mckenna, W. J.
    Elliott, P. M.
    Pennell, D. J.
    Prasad, S. K.
    EUROPEAN HEART JOURNAL, 2010, 31 : 331 - 331
  • [9] Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
    O'Hanlon, Rory
    Grasso, Agata
    Roughton, Michael
    Moon, James C.
    Clark, Susan
    Wage, Ricardo
    Webb, Jessica
    Kulkarni, Meghana
    Dawson, Dana
    Sulaibeekh, Leena
    Chandrasekaran, Badri
    Bucciarelli-Ducci, Chiara
    Pasquale, Ferdinando
    Cowie, Martin R.
    McKenna, William J.
    Sheppard, Mary N.
    Elliott, Perry M.
    Pennell, Dudley J.
    Prasad, Sanjay K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (11) : 867 - 874
  • [10] Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy
    Fang, Lu
    Ellims, Andris H.
    Beale, Anna L.
    Taylor, Andrew J.
    Murphy, Andrew
    Dart, Anthony M.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (11): : 5063 - 5073